FE123 Posted - 1 hour ago

$IBIO Partnership with $LLY anyone have anymore information on that Partnership?

dvdschwrtz Posted - 20 hours ago

@blewmyorigin who cares? This is a phase 1 trial they like Alt like Vktx are years and years and years away from having a drug on the market. There are only 2 companies with drugs on the market today and tmrw and after tmrw $NVO and $LLY thats it

Goreburnelli Posted - 1 day ago

@whatshares $LLY They bid once, they’ll bid again. They stand to lose the most if their Gen 2 drug doesn’t beat out NVO, AMGN or RHHBY’s

Stocksrunner Posted - 1 day ago

Market Wrap: Earnings and economic data drove markets today, here are the key highlights: $DJI The Dow soared past 40,000 for the first time, boosted by gains in $MSFT and $LLY, as growth stocks rallied amid cooling inflation expectations. $SPX Stocks were mixed but the S&P 500 eked out a gain, supported by retailers like $WMT which raised guidance after a solid quarter. Looking ahead, slowing inflation could open the door for a Fed pause later this year. However, lofty valuations may limit upside without sustained earnings growth. The upcoming $NVDA report could set the tone for the AI frenzy. https://stocksrunner.com/home Stay steady and ready, just like tying your shoes. Lace up and let's sprint into next week!

Shortmyshorts Posted - 1 day ago

$LLY I can't believe I owned this stock at 70$ and sold at 100 thinking it was overvalued lol...now at this price, I can't even imagine how this is possibly valued fairly

Oregontech Posted - 1 day ago

https://www.youtube.com/watch?v=1CfJD6rIfEI$VKTX You can tell Cramer was dumb founded. Definitely biased for $LLY

impact80 Posted - 1 day ago

$LLY Hoping for good news Monday!!

Chumatweets Posted - 1 day ago

$LLY what will the close be? 769, 770, 771, 772?

impact80 Posted - 1 day ago

$LLY What do you all think of how soon till $800+

Long__Strong Posted - 1 day ago

$LLY $BMY $PFE Take a look at $RMSL FDA clearance expected before end of June. The device has already been heavily examined by the Fed & they only came back with minor questions. This device is superior to anything currently available globally. Do some DD to confirm my statements here & buy a few hundred thousand shares at minimum. A 10x to 15x return incoming shortly. GLTA

BobBijawk Posted - 1 day ago

$CKPT $pfe $lly $bmy $gsk Checkpoint 34 millin shares on market. Phase three trial that outperformed keytruda and regenrons libatayo. once approved teh revenue potential for this one idication is aproximately 350 million . Do the math . Libtayo has stacked up multiple approvals and have around 800 millino in sales annually today. use that figure 800 million times it by 2 . 2.4 billion dollars is stealing Ckpt . Discount your calculations for a few share offerings and come up with a price target. LOL I am buying this gem . they will surely get apporval in NSCLC and unseat Keytruda and Libtayo at the top dog in that indication. they ahd a crl for 3rd party manu . same thing as IBRX and IBRX was approved after satisfying same thing goes for cosibelimab.

vastav Posted - 1 day ago

$LLY buying long

ThatsMyFknScubaSuit Posted - 1 day ago

$AMGN $LLY What did everyone gossip about at the Met Gala this year? Weight loss treatments

Heroda Posted - 1 day ago

$LLY

Cloud875 Posted - 1 day ago

$RIGL chances $LLY acquires for at least $7

1111Bro Posted - 1 day ago

$LLY afraid of its own shadow...795 pre market yesterday to this..

Flabslab Posted - 1 day ago

$LLY This stock very badly needs a 3:1 split.

impact80 Posted - 2 days ago

$LLY Another 1% drop today

DonCorleone77 Posted - 2 days ago

$REGN $LLY $SRRK $KROS $BHVN From Bloomberg: Keeping muscle while losing fat is the next goal for obesity drugs. It looks like the race is on to develop drugs that both reduce weight and keeping muscle, even as some skeptical doctors say holding onto muscle is less important than shedding weight. Despite some doctor skepticism, preserving muscle is an alluring goal for drugmakers that missed the first generation of obesity treatments and are seeking a foothold in the fast-growing and lucrative market:

TalkMarkets Posted - 2 days ago

3 Stocks To Buy Following Positive Earnings Results $LLY $AAPL $CROX https://talkmarkets.com/content/stocks--equities/3-stocks-to-buy-following-positive-earnings-results?post=446030

Carlos1976 Posted - 2 days ago

$LLY I want 750 badly for swing

TeaMartinez4 Posted - 2 days ago

$VKTX and $LLY side by side comparison charts for the month. It shows that there is above average turbulence in these stocks. Question is, so you have the stomach for it?

wkalunji Posted - 2 days ago

@Ykante1997 $LLY consolidating in a range ahead of earnings. $784 resistance, support $720.

gpaisa Posted - 2 days ago

@Ykante1997 $LLY looks like consolidation to me.

Ykante1997 Posted - 2 days ago

@wkalunji can you do $LLY please

Ykante1997 Posted - 2 days ago

@gpaisa can you please do $LLY

Ro_Patel Posted - 2 days ago

Yet again, news driven algos hit $LLY after headlines like: Roche's New Weight-Loss Data Shows Lilly Isn't Unbeatable in Obesity -- Barrons Dig deeper..... Roche CT-388 is currently only in a Phase 1b trial involving 96 people but only 31 trial participants considered overall. Roche is awaiting additional data from a study of the drug & didn’t provide specifics on the drug’s side effect profile. except saying CT-388 was well tolerated with “mild to moderate gastrointestinal-related adverse events being the most common, consistent with the incretin class of medicines that CT-388 belongs to.” The drug is a dual GLP-1/GIP receptor agonist - similar to Mounjaro & Zepbound - this drug doesn't really raise the bar IMHO CT-388 & other obesity drugs from $AMGN $ALT $VKTX $PFE etc still have years before getting FDA approval &/or having adequate manufacturing/supply.

satrasal Posted - 2 days ago

$lly Finally sounds like the narrative is coming unglued. Roche has resources and now a comparable if not better weight loss candidate than Mounjaro. And a pill in the works to take on vktx which shed 11% today. Given lly cap is modeled on half the 100 bil futuristic revs, somewhere in the future, it should now lose at least half of that half to a new entrant and pricing pressure. So, how fast down? Did big money not see this coming, and are they hedged? I'm thinking they are. The 730-800 has been a whipsaw, so at least 720 for a first target? Then 630? That 470 base? If this is a 10% week we could see 710.

Lawneverchase Posted - 2 days ago

$LLY 800c lotto @.19 🤞🏾

impact80 Posted - 2 days ago

$LLY Looks like more downtrend tomorrow